A clinical trial to study the effects of two formulations , Mutrakruchchrahara Kwath and Shatavari Gokshura Kwath in patients with Pittaj Mutrakruchra with special reference to urinary tract infection.

Phase 2

Active, not recruiting

Conditions: Urinary tract infection, site notspecified,

Registration Number: CTRI/2019/10/021480

Lead Sponsor: Sharang Arun Shirke

Brief Summary: THIS STUDY IS RANDOMIZED OPEN CONTROLLED CLINICAL STUDY TO ASSESS THE EFFECT OF MUTRAKRUCHCHRAHARA KWATH, 50 ML TWICE A DAY, AFTER MEAL, WITH LUKE WARM WATER, FOR DAYS AND GOKSHURA SHATAVARI KWATH, 50 ML, TWICE A DAY, AFTER MEAL, WITH LUKE WARM WATER, FOR 7 DAYS IN PATIENTS OF PITTAJ MUTRAKRUCHRA.

PATIENTS WITH AGE 20 TO 60 YEARS , BOTH GENDERS,WITH FOLLOWING SYMPTOMS WILL BE RANDOMLY SELECTED FOR TRIAL.

1) MUTRADAHA I.E.BURNING MICTURITION

2) MUHURMUHUR MUTRAPRAVRUTTI I.E. FREQUENCY OF MICTURITION.

3) SARUJA I.E. PAIN WHILE MICTURITION

4) SARAKTA MUTRATA I.E. RBC IN URINE EXAMINATION .

5) URINE EXAMINATION SHOWING PUS CELLS UPTO 10 HPF

STUDY WILL BE CONDUCTED IN SAME INSTITUTE TILL THE SAMPLE SIZE IS COMPLETED.

PRIMARY OUTCOME WILL BE REDUCTION OF SYMPTOMS RELATED TO URINARY TRACT INFECTION ALSO REDUCTION IN PUS CELLS.

INTERVENTION DURATION FOR EACH PATIENT WILL BE 7 DAYS.

PATIENTS URINE WILL BE EXAMINED ON DAY 0 AND DAY 7 .

CONCLUSION WILL BE DRAWN ON ANALYSIS BASED ON SYMPTOM REDUCTION AND PUS CELLS REDUCTION IN BOTH GROUPS.

Detailed Description: Not available

Recruitment & Eligibility

Status: Closed to Recruitment of Participants

Sex: All

Target Recruitment: 60

Inclusion Criteria

Patient having sign and symptoms of pittaj Mutrakruchchra. Patients irrespective of gender, economic class, caste, religion. Urine routine examination.
pus cells upto 10hpf.

Exclusion Criteria

Pregnancy and lactating mother Patients with malignancy, diabetes mellitus, BPH, pyelonephritis, traumatic cause UTI associated with calculus which need surgical intervention Known HIV and HbSAg positive patients.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
NORMALIATION OF PUSS CELL COUNT	7 days
REDUCTION OF SYMPTOMS LIKE BURNING MICTURITION , FREQUENCY OF URINATION, HEAMATURIA, PAINFUL MICTURITION.	7 days

Secondary Outcome Measures

Name	Time	Method
NORMALIATION OF PUSS CELL COUNT	REDUCTION OF SYMPTOMS LIKE BURNING MICTURITION , FREQUENCY OF URINATION, HEAMATURIA, PAINFUL MICTURITION.

Trial Locations

Locations (1): Yashwant Ayurved College Postgraduate Training and Research Centre
🇮🇳
Kolhapur, MAHARASHTRA, India
Yashwant Ayurved College Postgraduate Training and Research Centre
🇮🇳Kolhapur, MAHARASHTRA, India
VD SURYAKIRAN P WAGH
Principal investigator
9822846910
SURYAKIRAN_WAGH@REDIFFMAIL.COM